Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study

Movement Disorders

Volumn 25, Issue 3, 2010, Pages 349-356

  Winter, Yaroslav ^a   Bezdolnyy, Yury ^b   Katunina, Elena ^b   Avakjan, Gagik ^b   Reese, Jens P ^a   Klotsche, Jens ^c   Oertel, Wolfgang H ^a   Dodel, Richard ^a   Gusev, Eugene ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Epidemiology; Incidence; Multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASIA; COMORBIDITY; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; EUROPE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROSPECTIVE STUDY; RUSSIAN FEDERATION; SEX RATIO; SHY DRAGER SYNDROME; TREMOR;

AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; ODDS RATIO; PARKINSON DISEASE; PARKINSONIAN DISORDERS; RUSSIA; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 77649143605     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22966     Document Type: Article

References (45)

1. Winter Y, von Campenhausen S, Popov G, et al. Costs of Illness in a Russian cohort of patients with Parkinson's disease. Pharma-coEconomics 2009;27:571-584.
2. Winter Y, von Campenhausen S, Brozova H, et al. Costs of illness of Parkinson's disease in Eastern Europe: a Czech cohort study. Parkinsonism Relat Disord (in press).
3. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007;68:384-386.
4. United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2008 revision, Working Paper No. ESA/P/WP.210, 2009. Available at: http://www.gks.ru/wps/portal/!ut/p/. Accessed January 2009.
5. Russian State Committee for Statistics. Available at: http://www.gks.ru/wps/portal/!ut/p/. Accessed January 2009.
6. Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-827.
7. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of Parkinsonism in Olmsted county, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
8. MacDonald BK, Cockerell OC, Sander JW, Shorvon SD. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123 (Pt 4):665-676.
9. Granieri E, Carreras M, Casetta I, et al. Parkinson's disease in Ferrara, Italy, 1967 through 1987. Arch Neurol 1991;48:854-857.
10. de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of Parkinsonism and Parkinson disease in a general population: the Rotterdam study. Neurology 2004;63:1240-1244.
11. Benito-Leon J, Bermejo-Pareja F, Morales-Gonzalez JM, et al. Incidence of Parkinson disease and Parkinsonism in three elderly populations of central Spain. Neurology 2004;62:734-741.
12. Alves G, Muller B, Herlofson K, et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009;80:851-857.
13. van den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-1022.
14. von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsy-chopharmacol 2005;15:473-490.
15. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003;18:19-31.
16. Ashok PP, Radhakrishnan K, Sridharan R, Moussa ME. Epidemiology of Parkinson's disease in Benghazi, North-East Libya. Clin Neurol Neurosurg 1986;88:109-113.
17. Taba P, Asser T. Incidence of Parkinson's disease in Estonia. Neuroepidemiology 2003;22:41-45.
18. Wender M, Pruchnik D, Kowal P, Florczak J, Zalejski M. Epidemiology of Parkinson disease in the Pozna'n province. Przeglad epidemiologiczny 1989;43:150-155.
19. Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ. Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA. Chin Med J 1991;104:960-964.
20. Tan LC, Venketasubramanian N, Jamora RD, Heng D. Incidence of Parkinson's disease in Singapore. Parkinsonism Relat Disord 2007;13:40-43.
21. Chen RC, Chang SF, Su CL, et al. Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan county, Taiwan. Neurology 2001;57:1679-1686.
22. Yamawaki M, Kusumi M, Kowa H, Nakashima K. Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century. Neuroepidemiology 2009;32:263-269.
23. Ministry of Health and Social Development of the Russian Federation. Available at: http://www.minzdravsoc.ru. Accessed April 2009.
24. Gibb WRG. Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J 1988;64:345-512.
25. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
26. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
27. Lang AE, Riley DE, Bergeron C. Cortical-basal ganglionic degeneration. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: WB Saunders; 1994. p 877-894.
28. Rektor I, Rektorova I, Kubova D. Vascular Parkinsonism - an update. J Neurol Sci 2006;248:185-191.
29. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
30. Hoehn MM, Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967;5:427-442.
31. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
32. Beck A, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Ger Psychiatry 1961;4:561-567.
33. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997;49:1284-1288.
34. Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999;354:1771-1775.
35. Wermuth L, Bech S, Petersen MS, Joensen P, Weihe P, Grand-jean P. Prevalence and incidence of Parkinson's disease in The Faroe Islands. Acta Neurol Scand 2008;118:126-131.
36. Golbe LI, Davis PH, Schoenberg BS, Duvoisin, RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988;38:1031-1034.
37. Radhakrishnan K, Thacker AK, Maloo JC, Gerryo SE, Mousa ME. Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. Neuroepidemiology 1988;7:159-164.
38. Litvan I. Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord 2003;18 (Suppl 6):S43-S50.
39. Taylor KS, Cook JA, Counsell CE. Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78:905-906.
40. Visser M, van Rooden SM, Verbaan D, Marinus J, Stiggelbout AM, van Hilten JJ. A comprehensive model of health-related quality of life in Parkinson's disease. J Neurol 2008;255:1580-1587.
41. Santangelo G, Vitale C, Trojano L, et al. Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia. J Neurol 2009;256:632-638.
42. Wullner U, Schmitz-Hubsch T, Antony G, et al. Autonomic dysfunction in 3414 Parkinson's disease patients enrolled in the German Network on Parkinson's disease (KNP e.V.): the effect of ageing. Eur J Neurol 2007;14:1405-1408.
43. Riedel O, Klotsche J, Spottke A, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol 2008;255:255-264.
44. Kulisevsky J, Pagonabarraga J. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment. Mov Disord 2009;24:1103-1110.
45. Kalbe E, Calabrese P, Kohn N, et al. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 2008;14:93-101.